TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Opthea ( (AU:OPT) ) has provided an announcement.
Opthea Limited has released its Corporate Governance Statement for the financial year ending June 30, 2025. The statement, approved by the board and current as of September 15, 2025, outlines the company’s adherence to the ASX Corporate Governance Council’s recommendations. This disclosure is crucial for maintaining transparency and accountability, impacting Opthea’s operations and positioning within the industry by ensuring compliance with regulatory standards.
The most recent analyst rating on (AU:OPT) stock is a Sell with a A$0.05 price target. To see the full list of analyst forecasts on Opthea stock, see the AU:OPT Stock Forecast page.
More about Opthea
Opthea Limited operates in the biotechnology industry, focusing on developing and commercializing therapies for eye diseases, particularly those related to retinal conditions.
YTD Price Performance: -25.93%
Technical Sentiment Signal: Sell
Current Market Cap: A$738.8M
See more insights into OPT stock on TipRanks’ Stock Analysis page.